38 related articles for article (PubMed ID: 10518361)
1. Correlation of cancer antigen 15-3 (CA15-3) serum level and bony metastases in breast cancer patients.
Fakhari A; Gharepapagh E; Dabiri S; Gilani N
Med J Islam Repub Iran; 2019; 33():142. PubMed ID: 32280648
[No Abstract] [Full Text] [Related]
2. Bone Lesions Detected on Breast MRI: Clinical Outcomes and Features Associated with Metastatic Breast Cancer.
Corines MJ; Coffey K; Dou E; Lobaugh S; Zheng J; Hwang S; Feigin K
J Breast Imaging; 2022; 4(6):600-611. PubMed ID: 37744182
[TBL] [Abstract][Full Text] [Related]
3. Use of urinary markers in cancer setting: A literature review.
Chiu L; Wong E; DeAngelis C; Chiu N; Lam H; McDonald R; Pulenzas N; Hamer J; Lao N; Chow E
J Bone Oncol; 2015 Mar; 4(1):18-23. PubMed ID: 26579485
[TBL] [Abstract][Full Text] [Related]
4. Haematological and biochemical analysis of blood samples from early and late stage breast cancer patients in India.
Shreya S; Shekher A; Puneet P; Prasad SB; Prakash Jain B
Bioinformation; 2023; 19(7):806-809. PubMed ID: 37901291
[TBL] [Abstract][Full Text] [Related]
5. Alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase activity in the sera of patients with esophageal cancer.
Jelski W; Kozlowski M; Laudanski J; Niklinski J; Szmitkowski M
Clin Exp Med; 2009 Jun; 9(2):131-7. PubMed ID: 19184326
[TBL] [Abstract][Full Text] [Related]
6. Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions.
Coleman R; Brown J; Terpos E; Lipton A; Smith MR; Cook R; Major P
Cancer Treat Rev; 2008 Nov; 34(7):629-39. PubMed ID: 18579314
[TBL] [Abstract][Full Text] [Related]
7. Metastatic breast carcinoma to bone disguised by osteopoikilosis.
Kennedy JG; Donahue JR; Aydin H; Hoang BH; Huvos A; Morris C
Skeletal Radiol; 2003 Apr; 32(4):240-3. PubMed ID: 12652341
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of alkaline phosphatase and bone-specific alkaline phosphatase for metastases in breast cancer: a systematic review and meta-analysis.
Jiang C; Hu F; Li J; Gao G; Guo X
Breast Cancer Res Treat; 2023 Nov; 202(2):233-244. PubMed ID: 37522998
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers and skeletal metastases.
Demers LM; Costa L; Lipton A
Cancer; 2000 Jun; 88(12 Suppl):2919-26. PubMed ID: 10898335
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers for assessment of bone metastases in patients with breast cancer.
Hou MF; Tsai LY; Tsai SM; Huang CJ; Huang YS; Hsieh JS; Chan HM; Wang JY; Chuang CH; Chen FM; Huang TJ
Kaohsiung J Med Sci; 1999 Aug; 15(8):452-60. PubMed ID: 10518361
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of urine deoxypyridinoline for detecting bone metastases in breast cancer patients.
Hou MF; Lin SB; Yuan SS; Tsai LY; Tsai SM; Hsieh JS; Huang TJ
Ann Clin Lab Sci; 2003; 33(1):55-61. PubMed ID: 12661898
[TBL] [Abstract][Full Text] [Related]
12. The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessment.
Lüftner D; Günther S; Flath B; Müller C; Echteroff K; Mergenthaler HG; Wernecke KD; Possinger K
Anticancer Res; 1999; 19(4A):2537-44. PubMed ID: 10470191
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of bone markers for detection of bone metastases in lung cancer patients.
Alataş F; Alataş O; Metintaş M; Colak O; Erginel S; Harmanci E
Clin Biochem; 2002 Jun; 35(4):293-6. PubMed ID: 12135691
[TBL] [Abstract][Full Text] [Related]
14. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
[TBL] [Abstract][Full Text] [Related]
15. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.
Seibel MJ; Woitge HW; Pecherstorfer M; Karmatschek M; Horn E; Ludwig H; Armbruster FP; Ziegler R
J Clin Endocrinol Metab; 1996 Sep; 81(9):3289-94. PubMed ID: 8784085
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
